의료용 해동 시스템 시장 보고서 : 제품 유형, 샘플 유형, 최종사용자, 지역별(2025-2033년)

The global medical thawing system market size reached USD 219.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 390.8 Million by 2033, exhibiting a growth rate (CAGR) of 6.3% during 2025-2033. The increasing prevalence of chronic diseases, the rising demand for regenerative and personalized medicines, and ongoing technological advancements represent some of the key factors driving the market.

A medical thawing system is used in healthcare facilities to thaw frozen biological specimens such as blood products, vaccines, and tissue samples safely and quickly. It employs a controlled process of heating and agitating the frozen specimen in a water bath, allowing it to thaw evenly without causing any damage to the sample. In addition to this, they help minimize the risk of contamination, ensure accurate and reliable test results, and reduce the risk of injury to healthcare workers handling frozen specimens. The medical thawing system meets strict regulatory standards for handling biological materials and is essential in ensuring the quality and efficacy of the thawed specimen. As a result, it is widely employed across various healthcare facilities as a reliable, efficient, and standardized device for ensuring the quality and efficacy of biological samples used in patient care and research.

Medical Thawing System Market Trends:

The rising number of individuals suffering from chronic diseases and viral and bacterial infections is one of the primary factors driving the market growth. In line with this, the growing inclination toward organ transplantation and an increase in organ donors combined with the surging demand for blood transfusions is creating a favorable outlook for the market. In addition to this, the expanding demand for regenerative medicine is fuelling the need for safe and efficient thawing of stem cells, tissues, and other biological samples, which, in turn, is contributing to the market growth. Moreover, innovative technological advancements, such as the integration of automation and robotics technology to enhance the efficiency and accuracy of thawing systems, are presenting remunerative growth opportunities for the market. Furthermore, the outbreak of the COVID-19 virus has impelled the collection of tissue specimens for researching the biological impact of the infection and identifying new therapeutic interventions and prevention strategies, which is positively impacting the market growth. Other factors, such as the rising geriatric population, increasing healthcare expenditure, growing number of people participating in blood donation campaigns, the escalating demand for personalized medicines, and extensive investments in research and development (R&D) projects to develop effective therapies for treating rare diseases, are strengthening the market growth.

Key Market Segmentation:

Product Type Insights:

• Manual
• Automated

Sample Type Insights:

• Blood
• Plasma
• Stem Cells
• Whole Blood
• Platelets
• Embryo
• Ovum
• Semen

End User Insights:

• Blood Banks
• Hospitals
• Tissue Banks
• Pharmaceutical and Biotech Companies
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for medical thawing system. Some of the factors driving the North America medical thawing system market included the growing prevalence of life-threatening chronic diseases, the increasing adoption of regenerative and personalized medicines, and the rising geriatric population.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global medical thawing system market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Barkey GmbH & Co. KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• 1. What was the size of the global medical thawing system market in 2024?
• 2. What is the expected growth rate of the global medical thawing system market during 2025-2033?
• 3. What are the key factors driving the global medical thawing system market?
• 4. What has been the impact of COVID-19 on the global medical thawing system market?
• 5. What is the breakup of the global medical thawing system market based on the product type?
• 6. What is the breakup of the global medical thawing system market based on the sample type?
• 7. What is the breakup of the global medical thawing system market based on the end user?
• 8. What are the key regions in the global medical thawing system market?
• 9. Who are the key players/companies in the global medical thawing system market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Thawing System Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Manual
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Automated
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Sample Type

• 7.1 Blood
  • 7.1.1 Market Trends
  • 7.1.2 Key Segments
    • 7.1.2.1 Plasma
    • 7.1.2.2 Stem Cells
    • 7.1.2.3 Whole Blood
    • 7.1.2.4 Platelets
  • 7.1.3 Market Forecast
• 7.2 Embryo
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Ovum
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Semen
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by End User

• 8.1 Blood Banks
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Hospitals
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Tissue Banks
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Pharmaceutical and Biotech Companies
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Barkey GmbH & Co. KG
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Biolife Solutions Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
  • 14.3.3 Boekel Scientific
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Cardinal Health Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 General Electric Company
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Helmer Scientific Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Hospicare Systems
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 labcold Limited
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 MMS Medical and Laboratory Supplies
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Sarstedt AG & Co. KG
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Sartorius AG
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Terumo Penpol Private Limited (Terumo Corporation)
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
  • 14.3.13 Thermo Fisher Scientific Inc.
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 Financials
    • 14.3.13.4 SWOT Analysis